We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Klotho: molecular mechanisms and emerging therapeutics in central nervous system diseases.
- Authors
Hosseini, Leila; Babaie, Soraya; Shahabi, Parviz; Fekri, Kiarash; Shafiee-Kandjani, Ali Reza; Mafikandi, Vida; Maghsoumi-Norouzabad, Leila; Abolhasanpour, Nasrin
- Abstract
Klotho is recognized as an aging-suppressor protein that is implicated in a variety of processes and signaling pathways. The anti-inflammatory, anti-apoptotic, anti-oxidant, and anti-tumor bioactivities of klotho have extended its application in neurosciences and made the protein popular for its lifespan-extending capacity. Furthermore, it has been demonstrated that klotho levels would reduce with aging and numerous pathologies, particularly those related to the central nervous system (CNS). Evidence supports the idea that klotho can be a key therapeutic target in CNS diseases such as amyotrophic lateral sclerosis, Parkinson's disease, stroke, and Alzheimer's disease. Reviewing the literature suggests that the upregulation of klotho expression regulates various signaling pathways related to autophagy, oxidative stress, inflammation, cognition, and ferroptosis in neurological disorders. Therefore, it has been of great interest to develop drugs or agents that boost or restore klotho levels. In this regard, the present review was designed and aimed to gather the delegated documents regarding the therapeutic potential of Klotho in CNS diseases focusing on the molecular and cellular mechanisms.
- Subjects
CENTRAL nervous system diseases; ALZHEIMER'S disease; AMYOTROPHIC lateral sclerosis; NEUROLOGICAL disorders; PARKINSON'S disease
- Publication
Molecular Biology Reports, 2024, Vol 51, Issue 1, p1
- ISSN
0301-4851
- Publication type
Article
- DOI
10.1007/s11033-024-09862-2